Longer Duration of Treatment with ICIs Associated with a Higher Rate of Complete Response Among Patients with MMRd Cancers By Ogkologos - March 5, 2025 603 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a systematic review of published studies Source RELATED ARTICLESMORE FROM AUTHOR In Memory of Hernán Cortés-Funes: Former ESMO President and Pioneer in Medical Oncology Immune Pathways Help Identify Patients with Cancer and HIV Most Likely to Experience Reservoir Decay with Anti-PD1 Therapy Shaping Future Oncology Leaders: ESMO Broadens Its Career Development Opportunities MOST POPULAR Will politics keep us from accessing EU science funding? July 25, 2022 如果您剛確診為肺癌患者，請來看看專家的回答 April 22, 2021 Researchers Turn On PTEN Tumor-Suppressor Protein in Cancer Cells June 14, 2019 细针穿刺活检：如何准备和会发生什么 March 8, 2023 Load more HOT NEWS From smouldering ash to a gleaming temple for cancer research: The... What can elephants teach us about cancer? Learning to Advocate for Yourself – An Important Skill! The Lung Immune Prognostic Index May Indicate Response to Immune Checkpoint...
